Artelo Biosciences (ARTL) Research & Development (2017 - 2025)

Artelo Biosciences (ARTL) has reported Research & Development for 9 consecutive years, with $893000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Research & Development fell 63.93% year-over-year to $893000.0 in Q4 2025; TTM through Dec 2025 was $5.4 million, a 9.51% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, down 9.51% from the prior year.
• Research & Development was $893000.0 for Q4 2025 at Artelo Biosciences, down from $1.3 million in the prior quarter.
• Over five years, Research & Development peaked at $2.5 million in Q4 2024 and troughed at $325000.0 in Q3 2024.
• A 5-year average of $1.3 million and a median of $1.3 million in 2021 frame the typical range for Research & Development.
• Across the five-year window, Research & Development tumbled 79.5% in 2024 and surged 292.31% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $1.3 million in 2021, then soared by 35.59% to $1.7 million in 2022, then rose by 23.06% to $2.1 million in 2023, then rose by 16.57% to $2.5 million in 2024, then sank by 63.93% to $893000.0 in 2025.
• The last three Research & Development figures came in at $893000.0 (Q4 2025), $1.3 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.